S&P 500   3,388.95 (+0.55%)
DOW   29,365.43 (+0.46%)
QQQ   237.08 (+1.00%)
AAPL   323.78 (+1.50%)
FB   217.68 (-0.06%)
MSFT   187.36 (+0.07%)
AMZN   2,180.37 (+1.15%)
CGC   21.70 (-1.09%)
NVDA   312.21 (+5.27%)
BABA   223.07 (+1.16%)
MU   59.58 (+3.17%)
GE   12.74 (-0.16%)
TSLA   921.39 (+7.34%)
AMD   58.91 (+3.55%)
T   38.59 (+0.86%)
F   8.00 (-0.74%)
BAC   34.75 (+1.37%)
DIS   141.41 (+1.63%)
GILD   67.17 (+0.24%)
S&P 500   3,388.95 (+0.55%)
DOW   29,365.43 (+0.46%)
QQQ   237.08 (+1.00%)
AAPL   323.78 (+1.50%)
FB   217.68 (-0.06%)
MSFT   187.36 (+0.07%)
AMZN   2,180.37 (+1.15%)
CGC   21.70 (-1.09%)
NVDA   312.21 (+5.27%)
BABA   223.07 (+1.16%)
MU   59.58 (+3.17%)
GE   12.74 (-0.16%)
TSLA   921.39 (+7.34%)
AMD   58.91 (+3.55%)
T   38.59 (+0.86%)
F   8.00 (-0.74%)
BAC   34.75 (+1.37%)
DIS   141.41 (+1.63%)
GILD   67.17 (+0.24%)
S&P 500   3,388.95 (+0.55%)
DOW   29,365.43 (+0.46%)
QQQ   237.08 (+1.00%)
AAPL   323.78 (+1.50%)
FB   217.68 (-0.06%)
MSFT   187.36 (+0.07%)
AMZN   2,180.37 (+1.15%)
CGC   21.70 (-1.09%)
NVDA   312.21 (+5.27%)
BABA   223.07 (+1.16%)
MU   59.58 (+3.17%)
GE   12.74 (-0.16%)
TSLA   921.39 (+7.34%)
AMD   58.91 (+3.55%)
T   38.59 (+0.86%)
F   8.00 (-0.74%)
BAC   34.75 (+1.37%)
DIS   141.41 (+1.63%)
GILD   67.17 (+0.24%)
S&P 500   3,388.95 (+0.55%)
DOW   29,365.43 (+0.46%)
QQQ   237.08 (+1.00%)
AAPL   323.78 (+1.50%)
FB   217.68 (-0.06%)
MSFT   187.36 (+0.07%)
AMZN   2,180.37 (+1.15%)
CGC   21.70 (-1.09%)
NVDA   312.21 (+5.27%)
BABA   223.07 (+1.16%)
MU   59.58 (+3.17%)
GE   12.74 (-0.16%)
TSLA   921.39 (+7.34%)
AMD   58.91 (+3.55%)
T   38.59 (+0.86%)
F   8.00 (-0.74%)
BAC   34.75 (+1.37%)
DIS   141.41 (+1.63%)
GILD   67.17 (+0.24%)
Log in

ASX:IDX - Integral Diagnostics Stock Price, Forecast & News

A$3.95
-0.11 (-2.71 %)
(As of 02/19/2020 02:09 PM ET)
Today's Range
A$3.93
Now: A$3.95
A$4.07
50-Day Range
A$3.65
MA: A$3.98
A$4.24
52-Week Range
A$2.32
Now: A$3.95
A$4.39
Volume1.44 million shs
Average VolumeN/A
Market Capitalization$768.45 million
P/E Ratio29.70
Dividend Yield2.43%
BetaN/A
Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia. The company provides its services through a network of 53 sites under the Lake Imaging, South Coast Radiology, and Global Diagnostics brands in Victoria, Queensland, and Western Australia, as well as through specialist Radiology Group, and Trinity MRI and Cavendish Radiology in Auckland, New Zealand. Integral Diagnostics Limited is headquartered in North Melbourne, Australia.

Industry, Sector and Symbol

Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone61 3 5339 0704

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$232.39 million
Cash FlowA$0.13 per share
Book ValueA$0.81 per share

Profitability

Miscellaneous

Employees928
Market Cap$768.45 million
Next Earnings Date2/21/2020 (Estimated)
OptionableNot Optionable

Receive IDX News and Ratings via Email

Sign-up to receive the latest news and ratings for IDX and its competitors with MarketBeat's FREE daily newsletter.


Integral Diagnostics (ASX:IDX) Frequently Asked Questions

What is Integral Diagnostics' stock symbol?

Integral Diagnostics trades on the ASX under the ticker symbol "IDX."

How often does Integral Diagnostics pay dividends? What is the dividend yield for Integral Diagnostics?

Integral Diagnostics announced a Interim dividend on Saturday, February 23rd. Stockholders of record on Tuesday, April 2nd will be given a dividend of 0.05 per share on Tuesday, April 2nd. This represents a dividend yield of 1.85%. The ex-dividend date is Friday, March 1st. View Integral Diagnostics' Dividend History.

When is Integral Diagnostics' next earnings date?

Integral Diagnostics is scheduled to release their next quarterly earnings announcement on Friday, February 21st 2020. View Earnings Estimates for Integral Diagnostics.

Has Integral Diagnostics been receiving favorable news coverage?

Media stories about IDX stock have trended negative this week, according to InfoTrie Sentiment. InfoTrie scores the sentiment of press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Integral Diagnostics earned a media sentiment score of -2.0 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 2.0 out of 10, meaning that recent press coverage is very unlikely to have an effect on the company's share price in the next several days. View News Stories for Integral Diagnostics.

Who are some of Integral Diagnostics' key competitors?

Who are Integral Diagnostics' key executives?

Integral Diagnostics' management team includes the folowing people:
  • Dr. Ian Kadish, CEO, MD & Director (Age 56)
  • Ms. Anne Lockwood, Chief Financial Officer
  • Dr. Chien Ping Ho, Exec. Director
  • Dr. Sally Sojan, Exec. Director
  • Mrs. Kathryn Davies BBus, GAICD, CPA, Company Sec.

What is Integral Diagnostics' stock price today?

One share of IDX stock can currently be purchased for approximately A$3.95.

How big of a company is Integral Diagnostics?

Integral Diagnostics has a market capitalization of $768.45 million and generates $232.39 million in revenue each year. Integral Diagnostics employs 928 workers across the globe.View Additional Information About Integral Diagnostics.

What is Integral Diagnostics' official website?

The official website for Integral Diagnostics is http://www.integraldiagnostics.com.au/.

How can I contact Integral Diagnostics?

The company can be reached via phone at 61 3 5339 0704.


MarketBeat Community Rating for Integral Diagnostics (ASX IDX)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  14 (Vote Outperform)
Underperform Votes:  13 (Vote Underperform)
Total Votes:  27
MarketBeat's community ratings are surveys of what our community members think about Integral Diagnostics and other stocks. Vote "Outperform" if you believe IDX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IDX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/19/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel